Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 11/20 | 0.83 |
| ▸ | THRA | P10827 | 8/20 | 0.56 |
| ▸ | RARB | P10826 | 6/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RARA | P10276 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12193436 | 0.95 | THRB (0.91) | THRBTHRARARBMEN1KMT2A | |
| SCHEMBL1401854 | 0.95 | THRB (0.91) | THRBTHRARARBMEN1KMT2A | |
| SCHEMBL101905 | 0.94 | THRB (0.89) | THRBTHRARARBMEN1KMT2A | |
| SCHEMBL11031162 | 0.91 | THRB (1.00) | THRBTHRARARBMEN1KMT2A | |
| SCHEMBL815739 | 0.91 | THRB (0.90) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL19456765 | 0.91 | THRB (0.77) | THRBTHRARARBMEN1KMT2A | |
| SCHEMBL6931228 | 0.89 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL187096 | 0.89 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL2289080 | 0.89 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 | |
| SCHEMBL4475071 | 0.89 | THRB (0.97) | THRBTHRAMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8057701-B2 | Trifunctional (meth)acrylate compound and polymerizable composition containing same | ADEKA CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20070238026-A1 | Holographic recording composition, optical recording medium and optical recording method | FUJIFILM CORPORATION (JP) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | PYM1, MT-CO1, MAT1A | THRB 341/4885THRA 426/4885RARB 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.